New cancer clinical trial: Trial of Pembrolizumab in Cancer of Unknown Primary

Published on: November 26, 2018 at 12:00PM
Condition:   Cancer of Unknown Primary Site
Intervention:   Drug: Pembrolizumab
Sponsors:   Imperial College London;   Merck Sharp & Dohme Corp.
Not yet recruiting
https://ift.tt/2BAry9a